Inhibiting autophagy by miR-19a-3p/PTEN regulation protected retinal pigment epithelial cells from hyperglycemic

Qiaoyun Gong1, Dawei Luo1, Haiyan Wang1

  • 1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China; National Clinical Research Center for Eye Diseases, Shanghai, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai, China; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, China; Shanghai Engineering Center for Precise Diagnosis and Treatment of Eye Disease, Shanghai, China.

Abstract

Insights

Diabetic retinopathy (DR) involves aberrant autophagy. Upregulating microRNA (miR)-19a-3p inhibits this process by targeting PTEN, protecting retinal cells and offering a potential therapy for DR.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Diabetic retinopathy (DR) is a complication of diabetes affecting the retina.
  • The role of autophagy, a cellular degradation process, in DR pathogenesis is not fully understood.
  • Understanding the molecular mechanisms of autophagy in DR is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role and molecular mechanism of autophagy in diabetic retinopathy (DR).
  • To explore the potential of microRNA (miR)-19a-3p as a therapeutic target for DR.

Main Methods:

  • Established in vivo diabetic rat and in vitro hyperglycemic retinal pigment epithelium (RPE) cell models.
  • Analyzed autophagic flux using transmission electron microscopy and mRFP-GFP-LC3 adenovirus.
  • Quantified miR-19a-3p, PTEN/Akt/mTOR pathway components, and autophagy-related proteins (LC3II/I, p62).
  • Assessed RPE cell apoptosis, migration, viability, and permeability using various assays.

Main Results:

  • Autophagy was aberrantly activated with autophagosome accumulation in DR models.
  • DR induced PTEN expression, inhibiting Akt/mTOR and promoting autophagy and apoptosis.
  • miR-19a-3p directly targeted PTEN, reversing these DR-associated changes.
  • Downregulating autophagy via miR-19a-3p, PTEN knockdown, or 3-MA treatment protected RPE cells.

Conclusions:

  • Upregulation of miR-19a-3p inhibits aberrant autophagy by targeting PTEN, protecting RPE cells from DR damage.
  • miR-19a-3p shows promise as a novel therapeutic target for inducing protective autophagy in early DR.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K